Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
about
HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function(-)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In Vitro.Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis.RANK receptor oligomerisation in the regulation of NFκB signalling.Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering.Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand.Immunohistochemical localization of key arachidonic acid metabolism enzymes during fracture healing in mice.Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor CellsSoluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant.Effect of radiation on the expression of osteoclast marker genes in RAW264.7 cells.Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities.Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotypeInhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions.Regulation of matrix metalloproteinase-9 protein expression by 1α, 25-(OH)₂D₃ during osteoclast differentiation.RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis.Enterococcus faecalis promotes osteoclastogenesis and semaphorin 4D expression.Reveromycin A-Induced Apoptosis in Osteoclasts Is Not Accompanied by Necrosis.Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.Silicate modulates the cross-talk between osteoblasts (SaOS-2) and osteoclasts (RAW 264.7 cells): inhibition of osteoclast growth and differentiation.Hematoma-inspired alginate/platelet releasate/CaPO4 composite: initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery.Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells.Icariin ameliorates dexamethasone‑induced bone deterioration in an experimental mouse model via activation of microRNA‑186 inhibition of cathepsin K.Amorphous, Smart, and Bioinspired Polyphosphate Nano/Microparticles: A Biomaterial for Regeneration and Repair of Osteo-Articular Impairments In-Situ.Inhibitory effect of sulphated polysaccharide porphyran (isolated from Porphyra yezoensis) on RANKL-induced differentiation of RAW264.7 cells into osteoclasts.In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation.Bone matrix regulates osteoclast differentiation and annexin A8 gene expression.
P2860
Q24644323-711ADFCB-6404-4A22-AC15-7988D112E453Q33749672-D52C9BEC-6CE6-4EA8-9B76-981B5D08C207Q33766770-68407D9B-E3AD-4E79-92E5-A61CA17303FDQ33825207-B1338A06-28E7-4AFC-94DF-742EFB1CFBEDQ34100366-D439A151-7A8E-45E9-BA71-5D5B37408748Q34500583-1F579C48-149B-4433-AE8B-0F6A4C08DD3FQ34585204-A3D0143B-4555-4BA3-A1C8-81A120AF91EEQ35091768-2A9CA556-CDE2-44E3-947E-CBEDC63B4818Q35830567-5B210542-84F7-4966-885F-9AE7908DA21CQ35853148-717EDBDB-F50E-4A95-9116-B04E7400526AQ36383174-AB7BC529-94CF-4DF6-A4EF-ECE577719EDBQ37109337-00866B46-1E5F-4E4F-A2B0-8133C45EE484Q37150998-9C40AED4-5E1D-4FDC-8F0B-2E6AE939E7ABQ37453332-F5068026-A0E0-4074-908C-13C460B7629EQ37681080-D7032A03-E7CF-4285-AC1F-778D272B4496Q37730794-037983F5-17C7-471C-8E26-E67273FA2158Q38733893-70F3501D-9904-43AE-B484-9CA89488E71BQ38857186-C96DA5B0-01E2-4271-92FE-9A96DEC82AB8Q38901830-1596F4EC-44F3-4120-9192-803FCC28F60FQ39139785-EF747794-98B2-4684-942B-30E2042D6E09Q39344647-746F61B7-1981-48B0-AD19-8BD76FB980FEQ39347876-10ABBB50-1FF8-47C0-9279-2B46541670CAQ39645392-EB5A809F-4B85-4EFD-AD85-DC3A6B7554E9Q41595578-A1FDDB63-BAEB-41CC-8B00-9141F36750B8Q41872391-38515D4C-1CD5-44ED-AF46-597258F5D233Q47276468-DB08B5C6-2529-4CB9-9A8A-9F4F2D239735Q48133926-A4B72CF1-90C9-423F-B2B8-5FD5589FF87FQ48144315-B7B36485-EE17-481D-B17A-AF61362DA78AQ51653497-4C81C8CD-4A75-4E6C-B099-022C50167055Q54386419-AED26C4D-6E86-420A-9D7F-4D7237775507
P2860
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@ast
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@en
type
label
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@ast
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@en
prefLabel
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@ast
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@en
P2093
P2860
P356
P1476
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line
@en
P2093
Anthony J O'Donoghue
Bethany L V Cuetara
Kevin P McHugh
Tania N Crotti
P2860
P2888
P304
P356
10.1290/0510075.1
P577
2006-07-01T00:00:00Z